Search Results

The FKH domain in FOXP3 mRNA frequently contains mutations in hepatocellular carcinoma that influence the subcellular localization and functions of FOXP3.

• Authors : Ren J; Department of Surgery, Chinese University of Hong Kong, Hong Kong, China; Shenzhen Research Institute (SZRI), Chinese University of Hong Kong, Shenzhen 518057, China.

Subjects: Mutation*; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics ; Cell Nucleus/Cell Nucleus/Cell Nucleus/*metabolism

• Source: The Journal of biological chemistry [J Biol Chem] 2020 Apr 17; Vol. 295 (16), pp. 5484-5495. Date of Electronic Publication: 2020 Mar 20.Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication

Record details

Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma.

• Authors : Xu LX; Departments of Gastroenterology and Hepatology.; He MH

Subjects: Mutation*; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics ; Genomics/Genomics/Genomics/*methods

• Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 Jun 01; Vol. 30 (6), pp. 990-997.Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic)

Record details

Hepatitis B virus core antigen mutations predict post-operative prognosis of patients with primary hepatocellular carcinoma.

• Authors : Jia J; Department of Laboratory Medicine, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, PR China.; Department of Laboratory Medicine, 105th Hospital of PLA, Hefei 230031, PR China.

Subjects: Mutation*; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*surgery ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*virology

• Source: The Journal of general virology [J Gen Virol] 2017 Jun; Vol. 98 (6), pp. 1399-1409. Date of Electronic Publication: 2017 Jun 22.Publisher: Microbiology Society Country of Publication: England NLM ID: 0077340 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations.

• Authors : Ke S; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Chen S

Subjects: Mutation*; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*complications ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics

• Source: Hepatology (Baltimore, Md.) [Hepatology] 2017 Jan; Vol. 65 (1), pp. 134-151. Date of Electronic Publication: 2016 Nov 25.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma.

• Authors : Kan Z; Pfizer Oncology, San Diego, California 92121, USA.; Zheng H

Subjects: Genome, Human* ; Mutation*; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics

• Source: Genome research [Genome Res] 2013 Sep; Vol. 23 (9), pp. 1422-33. Date of Electronic Publication: 2013 Jun 20.Publisher: Cold Spring Harbor Laboratory Press Country of Publication: United States NLM ID: 9518021 Publication Model: Print-Electronic Cited Medium:

Record details

Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma.

• Authors : Wang G; National Laboratory for Oncogene & Related Genes, Shanghai Cancer Institute, Shanghai, China.; Zhao Y

Subjects: Allelic Imbalance/Allelic Imbalance/Allelic Imbalance/*genetics ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics ; Gene Amplification/Gene Amplification/Gene Amplification/*genetics

• Source: Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2001 Jul; Vol. 31 (3), pp. 221-7.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9007329 Publication Model: Print Cited Medium: Print ISSN: 1045-2257 (Print)

Record details

Impaired interaction of mutant thyroid hormone receptors associated with human hepatocellular carcinoma with transcriptional coregulators.

• Authors : Lin KH; Department of Biochemistry, Chang-Gung University, Taoyuan, Taiwan 333, Republic of China. ; Wu YH

Subjects: Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*metabolism ; Liver Neoplasms/Liver Neoplasms/Liver Neoplasms/*metabolism ; Mutation/Mutation/Mutation/*physiology

• Source: Endocrinology [Endocrinology] 2001 Feb; Vol. 142 (2), pp. 653-62.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375040 Publication Model: Print Cited Medium: Print ISSN:

Record details

Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells.

• Authors : Lin KH; Department of Biochemistry, Chang-Gung University, Taoyuan, Taiwan, Republic of China.; Shieh HY

Subjects: Mutation*; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*metabolism

• Source: Molecular carcinogenesis [Mol Carcinog] 1999 Sep; Vol. 26 (1), pp. 53-61.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print Cited Medium: Print ISSN: 0899-1987 (Print)

Record details

Agricola

Record details

Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutations.

• Authors : Shen M; Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Chen S

Subjects: Class I Phosphatidylinositol 3-Kinases*/Class I Phosphatidylinositol 3-Kinases*/Class I Phosphatidylinositol 3-Kinases*/genetics ; Class I Phosphatidylinositol 3-Kinases*/Class I Phosphatidylinositol 3-Kinases*/Class I Phosphatidylinositol 3-Kinases*/immunology ; Receptors, Antigen, T-Cell*/Receptors, Antigen, T-Cell*/Receptors, Antigen, T-Cell*/immunology

• Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Jun 04; Vol. 73 (8), pp. 150. Date of Electronic Publication: 2024 Jun 04.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851

Record details